7th Vaccine & ISV Congress | Sitges, Barcelona | Spain | 2013

Registration now open!

27-29 October 2013

Confirmed Speakers
Maria-Elena Bottazzi (USA)
Jose Catell (Spain)
Tong-Ming Fu (USA)
Jonathan Heeney (UK)
Paul- Henri Lambert (SWZ)
Arnold Monto (USA)
Gepi Pantaleo (SWZ)
Greg Poland (USA)
Rino Rappuoli (ITY)
Juergen Richt (USA)
Polly Roy (UK)
Nancy Sullivan (USA)

Conference Chairs
Mariano Esteban, Professor of the Spanish Research Council (CSIC), Spain
Adolfo García-Sastre, Professor at Mount Sinai School of Medicine, USA

Scientific Committee
Pedro Alonso, Barcelona Institute for Global Health, Spain
Emilio A. Emini, Pfizer Inc., USA
José Esparza, Bill & Melinda Gates Foundation, Seattle, USA
Ken Ishii, National Institute of Biomedical Innovation, Japan
Stefan H. E. Kaufmann, Max-Planck-Institute for Infection-Biology, Germany
Paul-Henri Lambert, University of Geneva, Switzerland
Shan Lu, University of Massachusetts Medical School, MA, USA
Ab Osterhaus, Erasmus University Rotterdam, The Netherlands
Bali Pulendran, Emory Vaccine Center, Atlanta, USA
Rino Rappuoli, Novartis, Italy
Polly Roy, London School of Hygiene & Tropical Medicine, UK

Join us in Spain for the premier conference on vaccines and vaccination. The 7th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation.

If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2013.

The Vaccine & ISV Congress has enjoyed an exciting history covering all aspects of vaccines since 2007. Over this time a wealth of knowledge has been presented, including talks from eminent scientists such as Stanley A. Plotkin, Rino Rappuoli, Ab Osterhaus, Walter A. Orenstein, Myron M. Levine, Adel Mahmoud and Gregory A. Poland.

Topics will include:

• Human vaccines - infectious diseases (bacterial)
• Human vaccines - infectious diseases (viral)
• Human vaccines - infectious diseases (other)
• Human vaccines - non-infectious diseases
• Veterinary vaccines
• Vaccine safety
• Clinical studies and field trials
• Immunology / animal models
• Vectors / adjuvants / drug delivery
• Production / manufacturing
• Regulatory / societal / economic / programmatic / legislation Subjects

What previous delegates said:

"The Vaccine Congress provides high level and new and innovative ideas about the vaccine process."
"This congress covers all aspects related to vaccine development which are beneficial to the new researcher to gain knowledge and new ideas for future vaccine study."